Abstract Details

Title Implementation of a Quality Improvement Curriculum in Child Neurology Residency

Topic Neurologic ��ɫ��

Presentation(s) P05 - (-)

Poster/Presentation
Number 012

Objective

Background BACKGROUND: Quality Improvement (QI) is a major component of the Accreditation Committee on Graduate Medical ��ɫ�� (ACGME) core competencies required of all medical trainees. Currently, neither the Neurology Review Committee, nor the ACGME define the process by which this competency should be taught and assessed. We have developed a QI curriculum and assessed its efficacy using pre and post-curriculum questionnaires on resident comfort with QI project development.

Design/Methods DESIGN/METHODS: Residents are presented 3 QI lectures on topics that include health care improvement processes, patient safety, and methods for changing systems. Residents are subdivided into small groups and assigned a faculty mentor to develop and complete a QI project within an academic year aimed at improving health care delivery or clinical decision support. To assess their comfort with aspects of QI project development and barriers to implementing their projects, residents were surveyed before and after the curriculum. Results were analyzed using Kruskal-Wallis rank testing.

Results RESULTS: 11 residents completed the pre-curriculum questionnaire and 15 residents completed the post-curriculum questionnaire. Residents were significantly more likely to report confidence in their ability to identify and measure variations in clinical practice (p=0.04) and perform root cause analysis in assessing patient safety (p=0.02). Overall, 76% of residents expressed satisfaction with their QI curriculum experience at the end of the academic year. Barriers identified by residents in implementing successful QI projects included lack of time (100%) and unequal distribution of resident effort within groups (33%).

Conclusions CONCLUSIONS: A QI curriculum incorporated into our child neurology training program increases residents' confidence in their abilities to develop and implement QI projects. Lack of time and inequitable resident effort contributed to difficulties implementing resident QI projects.

Authors/Disclosures
Kiran P. Maski, MD (Boston Children'S Hospital) PRESENTER	An immediate family member of Dr. Maski has received personal compensation for serving as an employee of Sanofi Genzyme. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KemPharm. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hayes Legal Services. An immediate family member of Dr. Maski has stock in Sanofi Genzyme. The institution of Dr. Maski has received research support from Jazz Pharmaceuticals. The institution of Dr. Maski has received research support from NIH 5K23NS104267-2. The institution of Dr. Maski has received research support from Coverys. Dr. Maski has received publishing royalties from a publication relating to health care.
Tobias Loddenkemper, MD, FAAN	No disclosure on file
	No disclosure on file
David K. Urion, MD, FAAN (Children'S Hospital Boston)	Dr. Urion has nothing to disclose.
	No disclosure on file
	No disclosure on file
Alan Leviton, MD (Boston Children's Hospital)	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��